Safety of the BNT162b2 mRNA COVID-19 vaccine in children and adolescents with juvenile idiopathic arthritis: a tertiary-center early experience

BACKGROUND: Research on the COVID-19 vaccination in patients with underlying rheumatic disorders in pediatric age is lacking. We studied possible adverse events of the mRNA BNT162b2 vaccine against SARS-CoV-2 (Pfizer-BioNTech) in children and adolescents with juvenile idiopathic arthritis (JIA), and...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelgalil, Abobakr A., Bakry, Reima A., Muzaffer, Mohammed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294816/
http://dx.doi.org/10.1186/s43166-022-00143-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294816/
http://dx.doi.org/10.1186/s43166-022-00143-z

Ejemplares similares